Post Job Free
Sign in

Sales Representative

Location:
Fort Myers, FL
Salary:
$50,000
Posted:
March 02, 2021

Contact this candidate

Resume:

Hilda R. Grao-Martinez

***** ***** *****

Fort Myers, Fl 33913

239-***-****

*********@*****.***

Currently seeking a job as an Account Manager in a lucrative professional environment.

EXPERIENCE

June 1996-October 2016

• GlaxoSmithKline Pharmaceuticals- Miami, Fl

• Current Position-Respiratory Sales Specialist- Calling on PCPs and Pulmonologists in the Miami Territory.

• Involved in the sale of the respiratory line of GSK, which includes for Asthma: Advair, Flovent, Ventolin, and involved in the most recent launches:

• Asthma: Breo Ellipta (ICS/LABA), and Arnuity Ellipta (Fluticasone Furoate Inhalation Powder)

• COPD: Breo Ellipta (ICS/LABA), Incruse Ellipta (umeclidinium inhalation powder) and Anoro Ellipta

(umeclidinium and vilanterol inhalation powder, first FDA approved (2 dual long-acting bronchodilators in one inhaler).

2015 – 2016

Incentive compensation is presently based on NBRX of new products. The NBRX represents a patient that is prescribed your class of medicine for the first time within the last year. Current NBRX market share is 17.5% above the .02 behind the region, above the nation as well as the nation. 2012-2014

Incentive compensation was based on sales competencies, which involved product knowledge, business acumen, and mastering customer engagement. Sales were in no way shape or form used to determine representative’s ability to sell product. Assessments and simulations were to be taken every semester to determine additional compensation in addition to base salary, as well as costs, which were the manager’s observations on these competencies during field rides. This was the new incentive compensation plan acquired by GSK from June 2011 through December 2014. 2011

• 100% Club for Q1

2010

• Above and Beyond Award 4rth Quarter 2010 Invited to participate in the GSK US Pharma Sales

• Invited to participate in the GSK US Pharma Sales Competency Model Focus Group, November 12.

• October, 4Q10 Early View ranked in the top ten in the Region in the Flex Sales Force.

• August, 3Q10 Early View ranked in the top ten in the Region in the Flex Sales Force.

• September, 3Q10 Early View ranked in the top ten in the Region in the Flex Sales Force

• 100% Portfolio Achievement for 3rd Quarter 2010

• Top 30% myRank of the Nation for the 3rd Quarter 1010

• Hired as part of the CVMU3 Flex Sales Force adding Avodart, Vesicare, and Jalyn to my portfolio.

• Elected Coreg CR Product Point for district: Coordinate and Execute company’s objectives Elected to serve on the Coreg CR Advisory Board: Represent the region Reporting Marketing 2009

• Ruby Elite Tier-Winner’s Circle 2009 National Performance (Top 5% in the region) (Ranked 2 of 43 within Region) (Ranked 75 of 559 in the Nation)

• 2nd Place Team Champion Award (District Award)

• Awarded Spirit Award Top Product Performance-1st Qtr for Lovaza 2008

• Promoted to Pharmaceutical Senior Executive Sales Representative August 2008.

• Served as Product Point for Lovaza: Coordinated and Executed company’s objectives.

• Recognized by Florida Region 3rd and 2nd Quarter for achieving ABOVE 150% goal.

• Sales Excellence Award Top Third Ranking 1st and 2nd Quarter 2008

• Achievement Recognition for 100 Portfolio 2nd Quarter 2008

• Awarded Top Gun Award for Outstanding Sales Achievement-Highest Winner Circle 1st Quarter 2008

• Regional Spirit Award April 2008

2007

• Diamond Tier-Winner’s Circle 2007 Regional Performance (Ranked 1 of 27 within Region)

• 2007 TST of the Year-Coral Gables

• 2007 Veteran of the Year

• Awarded Spirit Award Top Product Performance-Requip RLS

• Served as Requip Product Point with Sole Responsibility leading Requip performance in 4th quarter to 262.4% Sales Goal Attainment securing Winner’s Circle status

• Served as Product Point and Launched Altabax

• Sales Excellence Award Top Third Ranking 1st and 3rd Quarter 2007

• Outstanding Sales Achievement Award-Highest Winner Circle Points 2nd and 3rd Quarter 2006

• Representative of the Month award August 2006

• Served as Paxil CR Product Point

• Business Impact Award Spring Quarter 2006

• Diversity Board Member 2006

2005

• Paxil CR Top Performer with Region 2005

• Served as Paxil CR Product Point

• Appointed to the 150 Point Club Winter 2005

• Business Impact Award-Requip RLS

• Diversity Board Member 2005

• Business Impact Award-Advair Summer 2005

• Recipient of the Leadership Initiative Award Spring Quarter 2004

• Spirit Award-for superior performance with NHP Managed Care initiative December 2004

• Great Growth Contest Paxil CR 1st Place 1.4% Growth

• Promoted to Executive I Pharmaceutical Representative

• Fish Award Recipient March 2004

• Facilitated Augmentin XR workshop Regional meeting

• Selected to attend the 31st Annual Clinical concepts in Otolaryngology Conference

• Recognized for Peer to Peer Clinical Review

2003

• National Spirit Award Winner Paxil CR 2003

• 100% Portfolio Club Winter 2003

• Spirit Award 100% Portfolio Achievement March 2003

• Above and Beyond District Performance Paxil CR

• Recognized as a “Model for Success” within Region for performance in 2002

• Recipient of 2003 Winning Formula Share Option Grant

• 100% Portfolio Achievement Fall Quarter

2002

• Emerald Tier-Winner’s Circle 2002 Regional Performance (Ranked 2 of 28 within Region) (Ranked 9 of 581 within the Nation)

• 100% Portfolio Achievement Fall Quarter

• 100% Portfolio Achievement Summer Quarter

• 100% Portfolio Achievement Spring Quarter

• Outstanding Sales Achievement Winter Quarter 2002 for Augmentin Adult

• 2001

• Ranked top 10% of sales force Quarter 1 and 2

• Level of Excellence awarded as recognition for IHD Impact Award for Sunmed Baycol Lunches

• Awarded a Spirit Award for getting Augmentin ES back as 2nd tier formulary at Neighborhood Health Plans

1999

• Ruby Tier –Winner’s Circle 1999 Regional Performance (Ranked 10 of 38 within region)

• Awarded 500 Avandia Stock Options

• Level of Excellence Award for Paxil Social Phobia highest market share growth in the District

• Level of Excellence Award for Paxil Social Phobia for highest market share growth in the Region 1998

• Promoted to Sr. Pharmaceutical Consultant

• Level of Excellence Award for Famvir Zoster Highest Growth 1997

• Level of Excellence Award for Augmentin Adult Growth Runner-Up 1.5

• Level of Excellence Award for Requip Top 5

• Level of Excellence Award for Augmentin Adult HSHG Runner-Up EDUCATION

Florida International University Miami, FL

Bachelor of Business Administration May 1981

Major: Finance Minor: International Business

Miami Dade Community College Miami, FL

Associate of Arts, with Honors May 1979

Phi Theta Kappa National Honor Society

COMPETENCIES

LANGUAGE SKILLS

Fluent in Spanish

COMPUTER SKILLS

Microsoft Office

Microsoft Word

Microsoft Excel

Microsoft PowerP



Contact this candidate